HRA
LIVE

Serial Number

85671952

Owner

HRA, LLC

Attorney

Shannon Hennessy Pulaski

Filing Date

Jul 9, 2012

Add to watchlist:

No watchlists yet
View on USPTO

HRA Trademark

Serial Number: 85671952 • Registration: 4363571

HRA is a trademark filed by HRA, LLC on July 9, 2012. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HRA, LLC (12 trademarks)

666 PLAINSBORO ROAD
PLAINSBORO, NJ 08536

Entity Type: 99

Trademark Details

Filing Date

July 9, 2012

Registration Date

July 9, 2013

Published for Opposition

January 15, 2013

Goods & Services

Downloadable electronic publications in the nature of periodic reports in the pharmaceutical, biomedical, and medical devices fields, namely, medical information on products, markets, industry, technologies, treatment, companies, procedures and therapies; downloadable electronic reports and databases on the subjects of pharmaceutical, biomedical, and medical device, and other medical products used in hospitals; downloadable electronic reports and databases on the subjects of the markets for, and usage of, such pharmaceuticals, biomedical products, and medical devices or other equipment and products used in hospitals; downloadable webinars in the field of medical information on products, markets, industry, technologies, treatment, companies, procedures and therapies; downloadable electronic reports regarding forecasts and analysis of current emerging technologies, their applications and markets; electronic reports regarding various products for markets, industries and technologies related to medical disorders; downloadable electronic reports and databases for research, development, marketing and planning in the pharmaceutical industry

Providing online access to computer databases for pharmaceutical, biomedical, and medical device marketing and business planning; providing online access to computer databases for biopharmaceutical research and development

Syndicated market research for healthcare and pharmaceutical, biomedical, and medical device companies; marketing consulting and primary market research services in the field of healthcare for pharmaceutical, biomedical, and medical device manufacturers with respect to market access, managed markets, retail and hospital pharmacy, pricing and reimbursement; Conducting business and market research surveys, market research, market analysis, business marketing consulting services, sales research and consulting, economic forecasting and analysis in the healthcare field, measurement of sales force effectiveness and identification of business strategies to improve effectiveness, all of the aforementioned services for pharmaceutical, biomedical, and medical device manufacturers; provision of business, marketing, and economic information in the field of physician groups services, health systems and hospitals, HMOs and insurance providers, regional market data, drug product and customer response data; providing an online computer database for advertising and marketing in the pharmaceutical, biomedical and medical device industries; business consulting services regarding databases for pharmaceutical, biomedical, and medical device research, marketing, development; business data analysis in the field of prescription drugs

Consulting services in the field of healthcare for pharmaceutical, biomedical, and medical device manufacturers; provision of healthcare information in the field of physician groups services, health systems and hospitals, HMOs and insurance providers, regional market data, drug product and customer response data; providing information in the field of medical disorders, namely, information on products that are available for use in connection with various medical technologies, medical treatments and medical therapies, information on the companies and industries that are providing and developing such products, technologies, treatments and therapies, and information on the current and potential markets for such products, technologies, treatments and therapies; providing information in the field of medical disorders, namely, information on medical products, medical technologies, medical treatments and medical therapies

Providing an online computer database for product research, development and planning in the pharmaceutical, biomedical, and medical device industries

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 23, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 23, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 23, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 30, 2023 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 30, 2023 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 30, 2023 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 29, 2023 APRE
TEAS SECTION 8 & 9 RECEIVED
Jun 30, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 9, 2022 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 7, 2019 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 7, 2019 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 7, 2019 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 24, 2019 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 9, 2018 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 25, 2015 TCCA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Nov 5, 2014 ASCK
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2013 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 31, 2013 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 7, 2013 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 15, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jan 15, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 26, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 12, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2012 CRFA
ASSIGNED TO LIE
Nov 28, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 1, 2012 GNRN
NON-FINAL ACTION E-MAILED
Nov 1, 2012 GNRT
NON-FINAL ACTION WRITTEN
Nov 1, 2012 CNRT
ASSIGNED TO EXAMINER
Oct 25, 2012 DOCK
NOTICE OF PSEUDO MARK MAILED
Jul 17, 2012 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2012 NWOS
NEW APPLICATION ENTERED
Jul 12, 2012 NWAP